Using bladder scans to plan repeat surgery for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial checks whether a bladder scan and score (VI-RADS from MRI) can help doctors choose the right way to do a second look surgery for non-muscle-invasive bladder cancer. The goal is to reduce the chance of needing extra (“secondary”) resections while still catching important disease early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older and being evaluated for bladder cancer that may need TURBT (bladder tumor removal).
- Your tumor has already been confirmed as non-muscle-invasive (examples include CIS, Ta, or T1) and you’re considered a candidate for a second-look resection (Re-TURBT).
- Your bladder MRI (using VI-RADS score) does not suggest muscle-invasive, locally advanced, or spread cancer (VI-RADS 1–2 only).
- There is no sign of spread on scans (no lymph node or distant spread allowed).
- You can safely go through all study procedures, and you’re able to sign written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the need for a second surgery for people with early-stage bladder cancer. It uses a simple urine test to see if the test can help decide whether a second operation is necessary, which could save some patients from an extra procedure.
This trial tests STM-416, given around the time you have surgery to remove recurring bladder tumors, to see if it can reduce the chance the cancer comes back. It is for people with high-risk early bladder cancer (non–muscle-invasive) who have already had standard treatment and now need another TURBT.
This trial tests if adding a special CT scan before bladder removal helps find muscle-invasive bladder cancer earlier. It includes people with different stages of bladder cancer who are planning to have their bladder removed.
This study looks at whether a second bladder surgery is still needed for people with high-risk bladder cancer who had a negative urine test after their first surgery.
This trial uses advanced MRI scanning to guide treatment decisions for muscle invasive bladder cancer. It aims to improve outcomes by personalizing therapy based on detailed imaging.
This trial is testing a new way to perform surgery for people with newly diagnosed non-muscle-invasive bladder cancer. The goal is to see if a special technique during the tumor removal procedure can help reduce the chance of the cancer coming back.
Hear when a new Non Muscle Invasive Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.